HF
OACC

HRT Financial’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

HRT Financial’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159K Buy
+14,920
New +$159K ﹤0.01% 3474

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HRT Financial's OACC Position: Q2 2026 in Review

HRT Financial opened a new position in Oaktree Acquisition Corp III Life Sciences (OACC) in Q2 2026: 14,920 shares worth $159K. The stake represents ﹤0.01% of the portfolio and ranks #3474 among its holdings.

50 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • HRT Financial held 14,920 shares of Oaktree Acquisition Corp III Life Sciences worth $159K as of Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences was a new HRT Financial position in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3474 holding.
  • 50 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.